Latest News Videos

Foreign trade figure and survey data on the private sector were in focus in this holiday-shortened week as the war in the Middle East continues, further raising concern for policymakers. In the U.S., data on external trade, private sector employment and consumer confidence gained attention. In Europe, latest inflation figures worsened the fears for policymakers, though the acceleration was expected due to the jump in crude oil prices. Manufacturing activity remained resilient in China.

In this week’s video, we’ll cover major biotech moves and breakthroughs - from Novartis and Merck’s blockbuster acquisitions to the first new Hunter syndrome therapy in two decades. We’ll also look at a promising alternative to daily insulin injections and the near-term catalyst for Q3 Bio, which has been hitting new 52-week highs.

In this video, we’ll be covering some of the biggest biotech stories of the week - from seizure concerns tied to Parkinson’s disease drugs to the impressive 180% rally in Tango Therapeutics. We’ll also look at why Shattuck Labs (STTK) is back in focus, how Python blood could inspire weight loss treatments, and a rising new player in non-opioid pain relief.

Central banks dominated the economics news flow this week as the announced their latest interest rate decisions in the backdrop of the escalating Middle East War and the consequent surge in crude oil price. Policymakers everywhere were increasingly concerned about the impact of an energy price shock on inflation and the real economy. The major central banks that announced policy decisions included those in the U.S., Eurozone, the U.K., Canada, Switzerland, Japan and Australia.